Not exact matches
Through their analysis the researchers detected damaged proteins in characteristic patterns in the samples of those patients
with early and advanced OA and RA, but were found at markedly lower levels in the samples of those in the control group — providing the researchers
with the identifiable
biomarkers necessary for
early detection and diagnosis.
This includes determining whether the drugs should be used
earlier on in cancer treatment, finding
biomarkers to predict response, and combining immunotherapy
with other treatments.
«Adding these two
biomarkers provided statistically significant improvement for all
early stage cancer versus healthy controls as well as other subcohorts when used
with the current gold standard
biomarker, CA 19 - 9,» said Ann Killary, Ph.D., professor of Translational Molecular Pathology.
Adding two blood - borne proteins associated
with cancer cell migration increases the predictive ability of the current
biomarker for pancreatic cancer to detect
early stage disease, a research team from The University of Texas MD Anderson Cancer Center reports in the Journal of the National Cancer Institute.
With obesity rates climbing during the past 20 years within the United States and colon cancer being the second - leading killer of men and women in the nation, these facts compelled Fenton and her team to conduct research which could identify the specific
biomarkers of obesity and
early - stage colon cancer and help in prevention efforts.
The authors anticipate that health care providers will use the
early - detection
biomarkers to test for their presence and levels in blood from pancreatic cancer patients and blood drawn from individuals
with a high risk of developing pancreatic cancer, including those who have a first - degree relative
with pancreatic cancer, are genetically predisposed to the disease, or who had a sudden onset of diabetes after the age of 50.
Scientific American spoke
with geneticist and oncologist Amanda Paulovich, director of the Fred Hutchinson's
Early Detection Initiative, about the work she and her team are doing to find
biomarkers that can identify cancer in its most formative stages.
This assessment may represent a powerful
biomarker to predict cancer progression for men
with early - stage prostate cancer.
«Specifically, we are looking at the effects of these
early factors on later levels of C - reactive protein (CRP), a
biomarker associated
with risk for cardiovascular and metabolic disease,» Metzger said.
In previous studies, the same group along
with others had demonstrated that microRNAs (miRNAs) produced by eukaryotic cells and viruses are present in human blood in highly stable, cell - free forms and these so called circulating miRNAs can serve as non-invasive
biomarkers for the
early diagnosis of various diseases, including viral diseases.
High levels of two novel urinary
biomarkers early in critical illness are associated
with adverse long - term outcomes in patients
with acute kidney injury (AKI), according to an international, multi-center study led by University of Pittsburgh School of Medicine Researchers.
These results not only suggest
early mitochondrial biogenesis deficits as a pathogenic mechanism, but also as a potential
biomarker and therapeutic target in individuals
with Friedreich's ataxia.
Such
biomarkers raise the possibility of
early diagnosis, since levels of certain compounds differ between healthy people and patients
with NPC, even before the onset of symptoms.
The majority of evidence fell into three categories: biological indicators or
biomarkers, such as leukocyte telomere length (LTL),
earlier occurrence or higher prevalence of medical conditions associated
with advanced age and premature mortality.
«Our present study shows examination of the gene expression profiles at the very
early age of initial clinical detection reveals both strong evidence of
early biological processes in ASD and abnormal signals
with the potential to serve as an
early, practical
biomarker of risk for the disorder in general pediatric settings.»
In further research, Dr. Evgenii Belykh, the leading research fellow on the project stated, «The imaging findings are being compared
with the histology and
biomarkers of disk degeneration that will eventually help to recognize and predict the disease
earlier, and help to choose the best treatment option for each patient.»
«These results also create an opportunity to learn more about how
early interventions
with anti-inflammatory medications, may help lessen osteoarthritis risks in ACL patients, especially those patients
with high levels of a particular
biomarker.»
Abnormal levels of the proteins may be useful
biomarkers that could help us study
early treatments to limit or reverse the damage to brain cells and even prevent the development of the full - blown disease,» said study author Edward Goetzl, MD, a Professor of Medicine
with the University of California, San Francisco, a researcher at the National Institute on Aging, and a scientist of NanoSomiX, Inc., a California - based biotechnology company that provided a grant for method development for the study.
In addition to her expert skill as a clinician, Dr. Frontera also has many research interests including identifying
biomarkers and predictors of
early brain injury and vasospasm / delayed cerebral ischemia after subarachnoid hemorrhage and their impact on outcome; determining the efficacy of therapeutic strategies and developing guidelines for the management of patients
with intracranial hemorrhage; evaluating the cost, length of stay, quality of life, functional and cognitive outcomes in a broader population of intracranial hemorrhage patients; developing guidelines for the integration of palliative care into the intensive care unit setting; and evaluating the relationship of Zika virus infection, Guillain - Barre, and other neurologic disorders.
With further research, the team says the concept could be adapted to monitor other
biomarkers besides calcium, to serve as
early warning systems for other gradually - developing illnesses like neurodegenerative diseases and hormonal disorders.
This may be associated
with sex hormones and their receptors, different body fat distribution and related
biomarkers, such as higher adiponectin, which are discussed
earlier.
Early phase trials with anti-PD-L1 and anti-PD-1 antibodies have shown clinical activity in RCC and early biomarker assessment suggests PD - L1 tumor expression may influence resp
Early phase trials
with anti-PD-L1 and anti-PD-1 antibodies have shown clinical activity in RCC and
early biomarker assessment suggests PD - L1 tumor expression may influence resp
early biomarker assessment suggests PD - L1 tumor expression may influence response.
develops
biomarkers for
early diagnosis and improved treatment of cancer,
with the objective of enabling personalised treatment at an
early stage.
She has been involved in the identification of
early biomarkers of placental damage in cohorts of patients at high risk of pregnancy complications,
with specific focus on the role of autoimmunity and of vascular inflammation.
We will be able to establish how protein levels in the blood taken at the very
early stages of MS correlate
with how the disease behaves ten years down the road, juxtaposing the
biomarker with clinical, genetic, and imaging data already available.»
The researchers, studying women
with node - negative breast cancer — the small,
early tumors sought by mammography — found that by adding E-cadherin to other
biomarkers that they have studied they are able to distinguish those patients
with a 90 percent long - term survival from those whose survival is only 44 percent.
The clinical biostatistics team has strong connection
with the Biometry department (Head A. Savignoni), the
early phase clinical trial and precision medicine unit where patients are treated
with drugs in development (Head C. Le Tourneau), the translational research department in particular the Circulating Tumor
Biomarkers laboratory (Charlotte Proudhon), and of course the other teams of the U900.
A comprehensive, collaborative research project is looking for protein
biomarkers that can be used for
early breast cancer detection
with blood tests.
Distinct brain volume changes correlating
with clinical stage, disease progression rate, mutation size, and age at onset prediction as
early biomarkers of brain atrophy in Huntington's disease
«Both total metabolic tumor volume (TMTV), computed on baseline PET, and end - of - induction PET (EOI PET) are imaging
biomarkers showing promise for
early risk stratification in patients
with high tumor - burden follicular lymphoma,» reported lead author Anne Ségolène Cottereau, MD, from Cochin Hospital, René Descartes University, Paris, France, and colleagues.
Sistiaga, Summons, and their colleagues plan to use similar geochemical
biomarker techniques, coupled
with micromorphological analysis, to analyze soil samples in Olduvai Gorge, Tanzania — a 1.8 - million - year - old site where some of the
earliest evidence of human ancestry have been discovered.
Simoa assays can detect
biomarkers associated
with brain injury and disease at much
earlier stages to understand the long - term effects and disease pathology.
The most clinically desirable
biomarkers are those associated
with early stage tumor development as they enable surgical removal of lesions before widespread metastasis.
But the number of women surviving this advanced stage of the disease is rising: A study published this month in Cancer Epidemiology,
Biomarkers & Prevention found that the five - year survival rate for women initially diagnosed
with metastatic breast cancer doubled from 18 % in the
early 1990s to 36 % in the last decade or so.
Autoimmune disease can be detected
with various
biomarkers, four to five years before you actually have clinical symptoms, so the key is to catch the process
early before the damage is done.
However, this
biomarker seems to be less useful for identifying asymptomatic cats
with early HCM.